Kenneth Janzon
Chief Tech/Sci/R&D Officer at Nordvacc Läkemedel AB
Net worth: 439 236 $ as of 2024-04-29
Kenneth Janzon active positions
| Companies | Position | Start | End |
|---|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Kenneth Janzon
Former positions of Kenneth Janzon
| Companies | Position | Start | End |
|---|---|---|---|
| INTERVACC AB | Director/Board Member | 2000-12-31 | 2018-06-13 |
| Founder | 2000-12-31 | 2018-06-13 | |
| Independent Dir/Board Member | 2000-12-31 | - |
Statistics
International
| Sweden | 3 |
Operational
| Director/Board Member | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Private companies | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Stock Market
- Insiders
- Kenneth Janzon
- Experience
